BELLOMO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.117
AS - Asia 1.001
EU - Europa 541
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 26
OC - Oceania 6
Totale 2.914
Nazione #
US - Stati Uniti d'America 1.082
SG - Singapore 438
CN - Cina 160
IT - Italia 146
HK - Hong Kong 141
BR - Brasile 131
RU - Federazione Russa 88
VN - Vietnam 65
DE - Germania 64
IE - Irlanda 58
KR - Corea 48
FR - Francia 41
BD - Bangladesh 36
GB - Regno Unito 29
FI - Finlandia 27
IN - India 24
CA - Canada 22
JP - Giappone 20
NL - Olanda 19
AR - Argentina 14
IQ - Iraq 13
RO - Romania 12
TR - Turchia 11
PL - Polonia 10
VE - Venezuela 10
ZA - Sudafrica 9
ES - Italia 8
AT - Austria 7
SE - Svezia 6
EC - Ecuador 5
ID - Indonesia 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
MX - Messico 4
PK - Pakistan 4
PY - Paraguay 4
TN - Tunisia 4
IS - Islanda 3
JM - Giamaica 3
LT - Lituania 3
NP - Nepal 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CL - Cile 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
NI - Nicaragua 1
PA - Panama 1
PG - Papua Nuova Guinea 1
RE - Reunion 1
SD - Sudan 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UA - Ucraina 1
ZM - Zambia 1
Totale 2.866
Città #
Singapore 322
San Jose 191
Hong Kong 137
Ashburn 101
Chandler 83
Dublin 58
Boardman 57
Seoul 48
Los Angeles 47
Santa Clara 45
Perugia 38
Moscow 35
Beijing 33
Lauterbourg 32
New York 32
The Dalles 31
Piscataway 26
Munich 23
Ho Chi Minh City 19
Tokyo 19
San Mateo 18
Dallas 16
Phoenix 16
Hanoi 14
São Paulo 14
Altamura 12
Milan 12
Brooklyn 11
Helsinki 11
Nuremberg 11
Turku 11
Rome 10
Timisoara 10
Wilmington 10
Chennai 9
Lawrence 9
Medford 9
Princeton 9
Buffalo 8
Warsaw 8
Boston 7
Da Nang 7
Denver 7
Hefei 7
Houston 7
Montreal 7
Amsterdam 6
Atlanta 6
Council Bluffs 6
Frankfurt am Main 6
London 6
Orem 6
Redmond 6
Andover 5
Auckland 5
Baghdad 5
Columbus 5
Dong Ket 5
Falkenstein 5
Falls Church 5
Lappeenranta 5
Manchester 5
Poplar 5
Stockholm 5
Vienna 5
Charlotte 4
Chicago 4
Curitiba 4
Johannesburg 4
Newark 4
Rio de Janeiro 4
Secaucus 4
Toronto 4
Turin 4
Caracas 3
Des Moines 3
Florence 3
Genoa 3
Groningen 3
Miami 3
Mumbai 3
Newquay 3
Shanghai 3
Tashkent 3
Al Hillah 2
Ankara 2
Baku 2
Belém 2
Betim 2
Brasília 2
Brescia 2
Bridgetown 2
Brixen 2
City of London 2
Córdoba 2
Exeter 2
Fortaleza 2
Goiânia 2
Guangzhou 2
Haiphong 2
Totale 1.847
Nome #
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 152
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 127
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 117
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 112
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 105
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 96
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 96
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 86
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 86
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 84
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 84
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 84
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 80
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 80
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 77
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 76
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 76
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 75
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 71
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 70
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 69
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 69
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 69
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 68
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 64
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 64
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 60
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 60
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 59
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 59
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 59
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 56
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 54
Research advancement in fluid biomarkers for Parkinson's disease 52
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? 42
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 33
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function 33
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 26
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 21
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 18
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 17
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 17
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 11
Totale 2.914
Categoria #
all - tutte 14.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202263 0 10 2 0 2 5 4 13 4 7 7 9
2022/2023259 9 60 8 17 19 22 0 20 91 1 8 4
2023/2024223 10 16 12 6 7 1 34 6 49 11 27 44
2024/2025680 7 55 51 37 54 44 55 66 115 43 101 52
2025/20261.545 95 119 62 197 208 131 252 77 146 143 75 40
2026/2027110 51 59 0 0 0 0 0 0 0 0 0 0
Totale 2.914